CTLA-4 (+49A/G) Polymorphism in Type 1 Diabetes Children of Sudanese Population

Abstract

Background Type 1 diabetes mellitus (T1DM) is an organ-specific T cell-mediated autoimmune disease, characterized by destruction of pancreatic islets. Cytotoxic lymphocyte antigen-4 (CTLA-4) is a negative regulator of T cell proliferation, thus conferring susceptibility to autoimmunity.
Aims This study aimed to investigate the association of CTLA-4 +49A/G (rs231775) polymorphism with a risk of T1DM in Sudanese children.
Methods This a case-control study included 100 children with T1DM, referred to the pediatric clinic at referral pediatric teaching hospital in Gezira State-Sudan. Hundred unrelated healthy controls were recruited from departments in the same hospital. Genomic deoxyribonucleic acid (DNA) was extracted from Ethylenediaminetetraacetic Acid (EDTA)-preserved blood using QIAamp DNA Blood Mini Kit (QIAamp Blood) (QIAGEN; Valencia, CA). The polymerase chain reaction PCR restriction fragment length polymorphism (PCR-RFLP) and sequencing were applied for the CTLA-4 (+49A/G) genotyping. The changes accompanied the polymorphism were evaluated using relevant bioinformatics tools.
Results The genotype and allele frequencies of the CTLA-4 (+49A/G) polymorphism were significantly different between the patients and controls (p = 0.00013 and 0.0002, respectively). In particular, the frequency of the G allele, GG homozygous genotype, and AG heterozygous genotype were significantly increased in patients than in controls ([28% versus 7%, odds ratio (OR) = 5.16, 95% confidence interval [CI] = 2.77-9.65, p = 0.00] [12% versus 2%, OR = 6.68, CI = 1.46-30.69, p = 0.01] [32% versus 10%, OR = 4.24, CI = 1.95-9.21, p = 0.00], respectively). The presence of the G allele (homozygous) showed an influence on the signal peptide polarity, hydrophobicity, and α-helix propensity of the CTLA-protein.
Conclusion The results further support the association of CTLA-4 (+49A/G) polymorphism and the risk of T1DM in our study population.

Keywords

CTLA-4 / polymorphism / type 1 diabetes Mellitus / Sudanese

References

[1] Zheng P, Wu Y, Guo Y, Lee C, Liu Y.B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc Natl Acad Sci U S A 1998;95(11):6284-6289

[2] Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA.CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174(03):561-569

[3] Wang XB, Giscombe R, Yan Z, Heiden T, Xu D, Lefvert AK.Expression of CTLA-4 by human monocytes. Scand J Immunol 2002;55(01):53-60

[4] Carreno BM, Bennett F, Chau TA, et al.CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000;165(03): 1352-1356

[5] Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG.Structure ofmurine CTLA-4 and its role in modulating T cell responsiveness. Science 2000;290(5492):816-819

[6] Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C.A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277(48):46478-46486

[7] Mäurer M, Loserth S, Kolb-Mäurer A, et al.A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 þ49) alters T-cell activation. Immunogenetics 2002;54(01):1-8

[8] Kavvoura FK, Ioannidis JP.CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. Am J Epidemiol 2005;162(01):3-16

[9] Alshareef SA, Omar SM, Hamdan HZ, Adam I.Cytotoxic T-lymphocyte antigen-4 þ49A/G polymorphisms in Sudanese adults with type 1 diabetes and latent autoimmune diabetes. BMC Res Notes 2019;12(01):769

[10] American Diabetes Association.Classification and diagnosis of Diabetes. Diabetes Care 2017;40(Suppl 1):S11-S24

[11] Haneda M, Noda M, Origasa H, et al.Japanese clinical practice guideline for diabetes 2016. Diabetol Int 2018;9(01):1-45

[12] Capriotti E, Calabrese R, Fariselli P, Martelli PL, Altman RB, Casadio R.WS-SNPs&GO: aweb server for predicting the deleterious effect of human protein variants using functional annotation. BMC Genomics 2013;14(Suppl 3):S6

[13] Ng PC, Henikoff S.Predicting deleterious amino acid substitutions. Genome Res 2001;11(05):863-874

[14] Deléage G, Roux B.An algorithm for protein secondary structure prediction based on class prediction. Anal Biochem 1987; 163:292-297

[15] Roseman MA.Hydrophilicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds. JMol Biol 1988;200(03):513-522

[16] Mosaad YM, Elsharkawy AA, El-Deek BS.Association of CTLA-4 (þ49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Immunol Invest 2012;41(01):28-37

[17] Osei K, Schuster DP, Amoah AG, Owusu SK.Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub- Saharan Africa: implications for transitional populations. J Cardiovasc Risk 2003;10(02):85-96

[18] Saleh HM, Rohowsky N, Leski M. The CTLA4-819 C/T and þ49 A/G dimorphisms are associated with type 1 diabetes in Egyptian children. Indian J Hum Genet 2008;14(03):92-98

[19] Benmansour J, Stayoussef M, Al-Jenaidi FA, et al.Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin Vaccine Immunol 2010;17(09):1473-1477

[20] Gunavathy N, Asirvatham A, Chitra A, Jayalakshmi M.Association of CTLA-4 and CD28 gene polymorphisms with type 1 diabetes in South Indian population. Immunol Invest 2019;48(06):659-671

[21] Wang B, Du W, Jia Y, Zhang X, Ma G.Cytotoxic T-lymphocyteassociated protein 4 þ49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis. Oncotarget 2017;8(06):10553-10564

[22] Tang ST, Tang HQ, Zhang Q, Wang CJ, Wang YM, Peng WJ.Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a metaanalysis. Gene 2012;508(02):165-187

[23] Ahmadi S, Rostamzadeh J, Khosravi D, Shariati P, Shakiba N.Association of CTLA-4 gene 49A/G polymorphism with the incidence of type 1 diabetes mellitus in the Iranian Kurdish population. Pak J Biol Sci 2013;16(24):1929-1935

[24] Ranjouri MR, Aob P, Mansoori Derakhshan S, Shekari Khaniani M, Chiti H, Ramazani A.Association study of IL2RA and CTLA4 gene variantswith type I diabetes mellitus in children in the northwest of Iran. Bioimpacts 2016;6(04):187-193

[25] Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A. CTLA-4 þ49 A/G polymorphismis associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract 2005;68(02):111-116

[26] Douroudis K, Laine AP, Heinonen M, et al. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum Immunol 2009;70(07):536-539

[27] Angel B, Balic I, Santos JL, Codner E, Carrasco E, Pérez-Bravo F.Associations of the CTLA-4 polymorphisms with type 1 diabetes in a Chilean population: case-parent design. Diabetes Res Clin Pract 2009;85(03):e34-e36

[28] Chistiakov DA, Savost’anov KV, Nosikov VV.CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet 2001;2:6

[29] Osei-Hyiaman D,Hou L, Zhiyin R, et al.Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes inWest Africans but not in Chinese. Diabetes 2001;50(09):2169-2171

[30] Kumar N, Kaur G, Kanga U, et al.CTLA4þ49G allele associateswith early onset of type 1 diabetes in North Indians. Int J Immunogenet 2015;42(06):445-452

[31] Cinek O, Drevínek P, Sumník Z, et al.The CTLA4 þ49 A/G dimorphism is not associated with type 1 diabetes in Czech children. Eur J Immunogenet 2002;29(03):219-222

[32] Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 2000;165(11):6606-6611

[33] Arafa RM, Desouky SM, Emam SM, Abed NT, Mohamed SY.Detection of cytotoxic T-lymphocyte associated antigen-4 gene polymorphismin type 1 diabetes mellitus. Egypt J Immunol 2015; 22(01):49-57

[34] Çelmeli F, Türkkahraman D, Özel D, Akçurin S, Yegin O.CTLA-4 (þ49A/G) polymorphismand type-1 diabetes in Turkish children. J Clin Res Pediatr Endocrinol 2013;5(01):40-43

[35] Korolija M, Renar IP, Hadzija M, et al.Association of PTPN22 C1858T and CTLA-4 A49G polymorphismswith type 1 diabetes in Croatians. Diabetes Res Clin Pract 2009;86(03):e54-e57

[36] Van der Auwera BJ, Vandewalle CL, Schuit FC, et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin Exp Immunol 1997;110(01):98-103

[37] Marron MP, Raffel LJ, Garchon HJ, et al.Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997;6(08): 1275-1282

[38] Chen Z, Fei M, Fu D, et al.Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Gene 2013;516(02):263-270

[39] Balic I, Angel B, Codner E, Carrasco E, Pérez-Bravo F.Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum Immunol 2009;70(02):116-120

[40] Lemos MC, Coutinho E, Gomes L, et al.The CTLA4 þ49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int J Immunogenet 2009;36(03):193-195

[41] Ahmedov G, Ahmedova L, Sedlakova P, Cinek O.Genetic association of type 1 diabetes in an Azerbaijanian population: the HLADQ, -DRB1*04, the insulin gene, and CTLA4. Pediatr Diabetes 2006;7(02):88-93

[42] Kristiansen OP, Larsen ZM, Pociot F.CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 2000;1(03):170-184

RIGHTS & PERMISSIONS

2021 Global Medical Genetics